With reference to its recent intimation titled ‘Biocon Biologics and Viatris Announce Insulin Glargine (insulin glargine-yfgn) Injection Will Be Offered Through the Walgreens Prescription Savings Club’, Biocon has informed that, to read the word ‘Press Release ‘as ‘Company Statement’. The company enclosed the Company Statement for the reference. The above information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.